Shanxi Qianyecao Biotech QYC
Ordered peptides from Shanxi Qianyecao Biotech QYC? Mail in a sample (US only) and let us test it.
Test my supplyShanxi Qianyecao Biotech QYC has a broad, current purity-focus record led by GHK-Cu and Tirzepatide, while Retatrutide is useful but more volatile. The catalog is dispersed: BPC-157 and Cagrilintide carry the clearest weaknesses, Tesamorelin is mixed but improving, and missing batch IDs limit confidence.
We investigated who actually operates Shanxi Qianyecao Biotech QYC — corporate records, ownership trails, web infrastructure, and how its lab results break down product by product. Read the full report before you order.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Shanxi Qianyecao Biotech QYC rows.
Cancel anytime
Ordered peptides from Shanxi Qianyecao Biotech QYC? Mail in a sample (US only) and let us test it.
Test my supply| Date | Result | Test | Lab | Purity | Dosage | Label | COA |
|---|---|---|---|---|---|---|---|
5 Sep 2026 | Pass | PT-141 Shanxi Qianyecao Biotech QYC | lab name | View COA | |||
4 Sep 2026 | Fail | Sermorelin Shanxi Qianyecao Biotech QYC | lab name | View COA | |||
5 Aug 2026 | Fail | Retatrutide Shanxi Qianyecao Biotech QYC | lab name | View COA | |||
5 Aug 2026 | Fail | Ipamorelin Shanxi Qianyecao Biotech QYC | lab name | View COA | |||
4 Aug 2026 | Fail | Retatrutide Shanxi Qianyecao Biotech QYC | lab name | View COA | |||
23 Jul 2026 | Pass | BPC-157 Shanxi Qianyecao Biotech QYC | lab name | View COA | |||
21 Jul 2026 | Pass | Tesamorelin Shanxi Qianyecao Biotech QYC | lab name | View COA | |||
21 Jul 2026 | Pass | Tirzepatide Shanxi Qianyecao Biotech QYC | lab name | View COA | |||
17 Jul 2026 | Fail | Cagrilintide Shanxi Qianyecao Biotech QYC | lab name | View COA | |||
17 Jul 2026 | Fail | TB-500 Shanxi Qianyecao Biotech QYC | lab name | View COA | |||
About Shanxi Qianyecao Biotech QYC test results from Finnrick
Shanxi Qianyecao Biotech QYC is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 11 peptides and 125 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Shanxi Qianyecao Biotech QYC peptides in this dataset are BPC-157 (8 tests), Cagrilintide (5 tests) and GHK-Cu (12 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 125 recent tests. It also includes 1 correction related to this vendor.
Ordered peptides from Shanxi Qianyecao Biotech QYC? Mail in a sample (US only) and let us test it.
Test my supply